CXCR5 and granular corneal dystrophy type II: The overexpression of C-X-C motif chemokine receptor 5 (CXCR5) is known to intensify the immunomodulatory effects of MSCs, and it decreases allergic contact dermatitis (ACD) (Zhang et al., 2017).